{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:20:23Z","timestamp":1770794423737,"version":"3.50.0"},"reference-count":40,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>The incidence of venous thromboembolism (VTE) in patients with acute lymphoblastic leukemia (ALL) receiving asparaginase-based induction is high despite primary thromboprophylaxis. Our aim was to derive and externally validate a VTE risk prediction model in patients with ALL receiving asparaginase-based induction. We conducted a multicenter retrospective cohort study of patients (aged \u226518 years) with newly diagnosed ALL receiving asparaginase-based induction. The derivation and external validation cohorts included 306 and 94 patients, respectively. Primary outcome was VTE at any site. A cause-specific Cox proportional hazards model stratified by thromboprophylaxis and center was performed to identify VTE risk factors in the derivation cohort. A risk prediction model for VTE at 30 days was derived using variables with P value &amp;lt; .05 in the multivariable model and was tested in the validation cohort. VTE risk factors on multivariable analysis in the derivation cohort included D-dimer \u22651 \u03bcg fibrinogen equivalent unit per mL (hazard ratio [HR], 2.64; 95% confidence interval [CI], 1.07-6.5) and hemoglobin (HR for each 1 g\/dL increment, 1.19; 95% CI, 1.06-1.34) at ALL diagnosis. A VTE risk score based on these variables distinguished between a 4% (95% CI, 0.72-12) and 20% (95% CI, 14-27) 30-day cumulative incidence of VTE in the derivation cohort, with similar findings in the validation cohort (area under the curve, 0.56). The negative predictive value for VTE at 30 days was 96% and 93% in the derivation and validation cohorts, respectively, and the positive predictive value was 20% in both. We derived and validated a model using D-dimer and hemoglobin, which stratifies VTE risk in patients with ALL receiving asparaginase-based induction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017862","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:21:21Z","timestamp":1761913281000},"page":"593-603","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL"],"prefix":"10.1182","volume":"10","author":[{"given":"Daniela R.","family":"Anderson","sequence":"first","affiliation":[{"name":"1Department of Family Medicine, University of Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Gangaraju","sequence":"additional","affiliation":[{"name":"2Division of Hematology-Oncology, Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafik George","family":"Sedhom","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9340-8771","authenticated-orcid":false,"given":"Eva N.","family":"Hamuly\u00e1k","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"},{"name":"5Department of Internal Medicine, OLVG Hospital, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-9000","authenticated-orcid":false,"given":"Tzu-Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"6Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-8198","authenticated-orcid":false,"given":"Kristin","family":"O'Dwyer","sequence":"additional","affiliation":[{"name":"7Department of Medicine, Wilmot Cancer Institute of University of Rochester, Rochester, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Carney","sequence":"additional","affiliation":[{"name":"8Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrasekar","family":"Muthiah","sequence":"additional","affiliation":[{"name":"9Division of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8945-5850","authenticated-orcid":false,"given":"Michaela","family":"Liedtke","sequence":"additional","affiliation":[{"name":"10Division of Hematology, Department of Medicine, Stanford Health Care, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-918X","authenticated-orcid":false,"given":"Talha","family":"Badar","sequence":"additional","affiliation":[{"name":"11Division of Hematology, Mayo Clinic, Jacksonville, FL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-9652","authenticated-orcid":false,"given":"Shai","family":"Shimony","sequence":"additional","affiliation":[{"name":"12Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0239-9265","authenticated-orcid":false,"given":"Renana","family":"Robinson","sequence":"additional","affiliation":[{"name":"13Institute of Hematology, Department of Medicine, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel"},{"name":"14Department of Medicine, Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-7845","authenticated-orcid":false,"given":"Kristen","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"15Division of Hematology, Washington University School of Medicine, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-8493","authenticated-orcid":false,"given":"Andriy","family":"Derkach","sequence":"additional","affiliation":[{"name":"16Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira","family":"Dinner","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4426-5743","authenticated-orcid":false,"given":"Bart J.","family":"Biemond","sequence":"additional","affiliation":[{"name":"17Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nemirovsky","sequence":"additional","affiliation":[{"name":"16Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah A.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"18Department of Internal Medicine, University of Chicago Medical Center, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjani D.","family":"Kapadia","sequence":"additional","affiliation":[{"name":"19Department of Internal Medicine and Pediatrics, University of Chicago Medical Center, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4912-2992","authenticated-orcid":false,"given":"Hannah","family":"Levavi","sequence":"additional","affiliation":[{"name":"20Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Bar-Natan","sequence":"additional","affiliation":[{"name":"21Division of Hematology and Medical Oncology at New York-Presbyterian Hospital\/Weill Cornell Medical Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Van Hyfte","sequence":"additional","affiliation":[{"name":"22Department of Population Health Science and Policy and Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karan","family":"Bansal","sequence":"additional","affiliation":[{"name":"2Division of Hematology-Oncology, Institute for Cancer Outcomes and Survivorship, The University of Alabama at Birmingham, Birmingham, AL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-2972","authenticated-orcid":false,"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[{"name":"6Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-5034","authenticated-orcid":false,"given":"Jill","family":"Fulcher","sequence":"additional","affiliation":[{"name":"6Department of Medicine, University of Ottawa at The Ottawa Hospital and Ottawa Hospital Research Institute, Ottawa, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke M.","family":"Gerrits","sequence":"additional","affiliation":[{"name":"23Department of Internal Medicine, OLVG, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9816-6302","authenticated-orcid":false,"given":"Mark R.","family":"Litzow","sequence":"additional","affiliation":[{"name":"24Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selina","family":"Luger","sequence":"additional","affiliation":[{"name":"25Division of Hematology\/Oncology and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guru Subramanian","family":"Guru Murthy","sequence":"additional","affiliation":[{"name":"9Division of Hematology-Oncology, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-4529","authenticated-orcid":false,"given":"Marlise","family":"Luskin","sequence":"additional","affiliation":[{"name":"12Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8662-0707","authenticated-orcid":false,"given":"Ofir","family":"Wolach","sequence":"additional","affiliation":[{"name":"13Institute of Hematology, Department of Medicine, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel"},{"name":"14Department of Medicine, Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-350X","authenticated-orcid":false,"given":"William","family":"Shomali","sequence":"additional","affiliation":[{"name":"26Department of Medicine, Stanford University School of Medicine\/Stanford Cancer Institute, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-6893","authenticated-orcid":false,"given":"Jeffrey I.","family":"Zwicker","sequence":"additional","affiliation":[{"name":"27Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"28Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Stock","sequence":"additional","affiliation":[{"name":"29Section of Hematology\/Oncology, Department of Medicine, University of Chicago, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avi","family":"Leader","sequence":"additional","affiliation":[{"name":"27Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"28Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"5","key":"2026021015531222900_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.16695","article-title":"Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy","volume":"191","author":"Sibai","year":"2020","journal-title":"Br J Haematol"},{"issue":"2","key":"2026021015531222900_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11239-017-1597-7","article-title":"The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia","volume":"45","author":"Grace","year":"2018","journal-title":"J Thromb Thrombolysis"},{"issue":"17","key":"2026021015531222900_bib3","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2217\/fon.15.114","article-title":"L-asparaginase and venous thromboembolism in acute lymphocytic leukemia","volume":"11","author":"Goyal","year":"2015","journal-title":"Future Oncol"},{"issue":"3","key":"2026021015531222900_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/leu.2012.290","article-title":"The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia","volume":"27","author":"Truelove","year":"2013","journal-title":"Leukemia"},{"issue":"22","key":"2026021015531222900_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","article-title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","volume":"131","author":"Rank","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2026021015531222900_bib6","doi-asserted-by":"crossref","first-page":"107694","DOI":"10.1016\/j.leukres.2025.107694","article-title":"Incidence and risk factors of venous thromboembolism in patients with acute leukemia: a systematic review and meta-analysis","volume":"153","author":"Zhang","year":"2025","journal-title":"Leuk Res"},{"issue":"2","key":"2026021015531222900_bib7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ajh.27171","article-title":"Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: a report from CYP-C","volume":"99","author":"Pelland-Marcotte","year":"2024","journal-title":"Am J Hematol"},{"issue":"17","key":"2026021015531222900_bib8","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1182\/bloodadvances.2022007699","article-title":"D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia","volume":"6","author":"Anderson","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"2026021015531222900_bib9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0039-3400303","article-title":"Development of a clinical prediction rule for venous thromboembolism in patients with acute leukemia","volume":"120","author":"Al-Ani","year":"2020","journal-title":"Thromb Haemost"},{"issue":"3","key":"2026021015531222900_bib10","first-page":"328","article-title":"Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 Study","volume":"136","author":"Orvain","year":"2020","journal-title":"Blood"},{"issue":"1","key":"2026021015531222900_bib11","doi-asserted-by":"crossref","first-page":"101353","DOI":"10.1016\/j.beha.2022.101353","article-title":"Thrombosis and bleeding in hematological malignancy","volume":"35","author":"Wang","year":"2022","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2026021015531222900_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT \u2013 a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"issue":"31","key":"2026021015531222900_bib13","doi-asserted-by":"crossref","first-page":"104347","DOI":"10.1016\/j.critrevonc.2024.104347","article-title":"A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including asparaginase or its prolonged form","volume":"197","author":"Hu","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"2026021015531222900_bib14","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1160\/TH17-02-0109","article-title":"Increasing incidence and recurrence rate of venous thromboembolism in paediatric oncology patients in one single centre over 25 years","volume":"117","author":"Klaassen","year":"2017","journal-title":"Thromb Haemost"},{"key":"2026021015531222900_bib15","author":"Lauw","year":"13-16  2024"},{"issue":"suppl 1","key":"2026021015531222900_bib16","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood-2023-178918","article-title":"Thromboprophylaxis with intermediate dose low molecular weight heparin in adults undergoing induction with L-asparaginase for acute lymphoblastic leukemia","volume":"142","author":"De Sa","year":"2023","journal-title":"Blood"},{"issue":"2","key":"2026021015531222900_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jth.14671","article-title":"The prevention and management of asparaginase-related venous thromboembolism in adults: guidance from the SSC on hemostasis and malignancy of the ISTH","volume":"18","author":"Zwicker","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2026021015531222900_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"issue":"2","key":"2026021015531222900_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"1","key":"2026021015531222900_bib20","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"10","key":"2026021015531222900_bib21","first-page":"CD013399","article-title":"Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia","volume":"10","author":"Rank","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"2026021015531222900_bib22","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","article-title":"Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia","volume":"128","author":"Libourel","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2026021015531222900_bib23","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2026021015531222900_bib24","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/jth.15048","article-title":"Definition of major bleeding: prognostic classification","volume":"18","author":"Franco","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2026021015531222900_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa1813865","article-title":"Pregnancy-adapted YEARS algorithm for diagnosis of suspected pulmonary embolism","volume":"380","author":"van der Pol","year":"2019","journal-title":"N Engl J Med"},{"issue":"17","key":"2026021015531222900_bib26","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1182\/blood-2008-08-175745","article-title":"Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival","volume":"113","author":"Ku","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2026021015531222900_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2018.02.150","article-title":"Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia","volume":"165","author":"Prasca","year":"2018","journal-title":"Thromb Res"},{"issue":"8","key":"2026021015531222900_bib28","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1097\/HS9.0000000000000750","article-title":"EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer","volume":"6","author":"Falanga","year":"2022","journal-title":"Hemasphere"},{"issue":"1","key":"2026021015531222900_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41408-024-01178-5","article-title":"Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen","volume":"14","author":"Shimony","year":"2024","journal-title":"Blood Cancer J"},{"issue":"9","key":"2026021015531222900_bib30","first-page":"e70078","article-title":"Venous thromboembolism prophylaxis in patients treated for acute lymphoblastic leukemia: a comprehensive systematic review and meta-analysis","volume":"16","author":"Al Lami","year":"2024","journal-title":"Cureus"},{"issue":"10","key":"2026021015531222900_bib31","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2026021015531222900_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12959-023-00506-2","article-title":"Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients","volume":"21","author":"Owattanapanich","year":"2023","journal-title":"Thromb J"},{"issue":"11","key":"2026021015531222900_bib33","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/jamaoncol.2023.3634","article-title":"Risk-directed ambulatory thromboprophylaxis in lung and gastrointestinal cancers: the TARGET-TP randomized clinical trial","volume":"9","author":"Alexander","year":"2023","journal-title":"JAMA Oncol"},{"issue":"7","key":"2026021015531222900_bib34","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1016\/S2352-3026(18)30063-2","article-title":"A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts","volume":"5","author":"Pabinger","year":"2018","journal-title":"Lancet Haematol"},{"issue":"2","key":"2026021015531222900_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.295.2.199","article-title":"Does this patient have deep vein thrombosis?","volume":"295","author":"Wells","year":"2006","journal-title":"JAMA"},{"issue":"3","key":"2026021015531222900_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.26440","article-title":"Increased blood viscosity and red blood cell aggregation in patients with COVID-19","volume":"97","author":"Nader","year":"2022","journal-title":"Am J Hematol"},{"key":"2026021015531222900_bib37","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3389\/fphys.2019.01329","article-title":"Blood rheology: key parameters, impact on blood flow, role in sickle cell disease and effects of exercise","volume":"10","author":"Nader","year":"2019","journal-title":"Front Physiol"},{"key":"2026021015531222900_bib38","doi-asserted-by":"crossref","first-page":"828702","DOI":"10.3389\/fped.2022.828702","article-title":"Thrombosis complications in pediatric acute lymphoblastic leukemia: risk factors, management, and prevention: is there any role for pharmacologic prophylaxis?","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front Pediatr"},{"issue":"3","key":"2026021015531222900_bib39","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/jth.13236","article-title":"Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study","volume":"14","author":"Tuckuviene","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"8","key":"2026021015531222900_bib40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1076029618788177","article-title":"Clinical course and complications of catheter and non-catheter-related upper extremity deep vein thrombosis in patients with cancer","volume":"24","author":"Mansour","year":"2018","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/593\/2500553\/blooda_adv-2025-017862-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/593\/2500553\/blooda_adv-2025-017862-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:53:24Z","timestamp":1770756804000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/3\/593\/548002\/Derivation-and-external-validation-of-a-venous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017862","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,10]]},"published":{"date-parts":[[2026,1,28]]}}}